Skip to main content

Table 3 Participant (patient) characteristics

From: The experience of foot problems and decisions to access foot care in patients with rheumatoid arthritis: a qualitative study

ID Gender Age (years) Disease duration (years) Current medication HAQ Patient global Foot global Accessed foot care
1 Male 61 3 Biologics, DMARDs, GC 2.875 6 6 Yes
2 Female 62 2 DMARDs, GC 0.375 2 3 No
3 Male 39 2 DMARDs, GC, NSAIDs 0 1 1 No
4 Male 55 27 Biologics, DMARDs, NSAIDs 2.75 8 9 Yes
5 Female 61 23 DMARDS, GC, NSAIDs 2.75 7 7 Yes
6 Male 54 2 Biologics, DMARDS, GC, NSAIDs 2 8 9 No
7 Female 71 11 Biologics 0.375 7 1 No
8 Male 72 20 DMARDs, NSAIDs 1.87 9 5 Yes
9 Female 46 24 Biologics, DMARDs, NSAIDs 2.375 6 8 Yes
10 Female 29 5 GC 0 0 0 No
11 Female 55 7 DMARDs, NSAIDs 1.87 5 7 Yes
12 Female 69 18 DMARDs 1.75 7 8 Yes
Mean   56.2 12.0   1.56 5.5 5.3  
Range   (29–72) (2–27)   (0–2.875) (0–9) (0–9)  
  1. Key:
  2. ID Patient identifier
  3. DMARDs Disease-modifying anti-rheumatic drugs
  4. GC Glucocorticoids
  5. NSAIDs Non-steroidal anti-inflammatory drugs
  6. HAQ Health Assessment Questionnaire score 0–3 (3 is most disabled)
  7. Patient Global = Numerical rating scale 0 (very well) -10 (10 very badly)
  8. Foot Global = Numerical rating scale 0 (no problem) -10 (10 severe problem)